TB following targeted and biological therapy: can we predict it? Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020
Who should receive which biologic and why? Current and future approaches in severe asthma patients Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what? Year: 2021
Failing a re-treatment regimen does not predict MDR/XDR tuberculosis: is “blind” treatment dangerous? Source: Eur Respir J 2011; 37: 1283-1285 Year: 2011
Can we predict tuberculosis cure? What tools are available? Source: Eur Respir J, 52 (5) 1801089; 10.1183/13993003.01089-2018 Year: 2018
Difficult-to-wean patients: can we avoid the problem? Source: ERS Skills Course 2016 Year: 2016
Pulmonary rehabilitation: can we identify the patients who will benefit most? Source: Eur Respir J 2001; 18: Suppl. 33, 187s Year: 2001
Diagnosis of tuberculosis in patients with psoriasis: the need for a modified approach Source: Eur Respir J 2011; 37: 232-233 Year: 2011
The paradoxes of asthma management: time for a new approach? Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017 Year: 2017
Diagnosis of tuberculosis in patients with psoriasis: the need for a modified approach Source: Eur Respir J 2011; 37: 231-232 Year: 2011
Practical approach to the difficult-to-wean patient: who, how and where? Source: ERS Skills Course 2016 Year: 2016
Should we treat every patient with latent TB? Is there a cost to pay? Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018
Tuberculosis exposure in a group of toddlers - what is the best strategy to prevent infections? Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020
Tuberculosis elimination, patients' lives and rational use of new drugs: revisited Source: Eur Respir J 2016; 47: 664-667 Year: 2016
What next? Basic research, new treatments and a patient-centred approach in controlling tuberculosis Source: Eur Respir Monogr 2018; 82: 414-429 Year: 2018
Non-tuberculous mycobacterial disease in patients who were referred as MDR-TB in resource limited settings: need for more rapid identification Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008
Managing severe asthma: do we need to do more? Source: Annual Congress 2007 - Changing practice with anti-IgE: patient, physician and payor perspectives Year: 2007